Predicting Cognitive Decline in Older Adults Using Baseline Metrics of AD Pathologies, Cerebrovascular Disease, and Neurodegeneration

Author:

Prosser LloydORCID,Macdougall AmyORCID,Sudre Carole H.ORCID,Manning Emily N.ORCID,Malone Ian B.ORCID,Walsh PhoebeORCID,Goodkin OliviaORCID,Pemberton HughORCID,Barkhof FrederikORCID,Biessels Geert JanORCID,Cash David M.ORCID,Barnes Josephine,

Abstract

Background and ObjectivesDementia is a growing socioeconomic challenge that requires early intervention. Identifying biomarkers that reliably predict clinical progression early in the disease process would better aid selection of individuals for future trial participation. Here, we compared the ability of baseline, single time-point biomarkers (CSF amyloid 1–42, CSF ptau-181, white matter hyperintensities (WMH), cerebral microbleeds, whole-brain volume, and hippocampal volume) to predict decline in cognitively normal individuals who later converted to mild cognitive impairment (MCI) (CNtoMCI) and those with MCI who later converted to an Alzheimer disease (AD) diagnosis (MCItoAD).MethodsStandardized baseline biomarker data from AD Neuroimaging Initiative 2 (ADNI2)/GO and longitudinal diagnostic data (including ADNI3) were used. Cox regression models assessed biomarkers in relation to time to change in clinical diagnosis using all follow-up time points available. Models were fit for biomarkers univariately and together in a multivariable model. Hazard ratios (HRs) were compared to evaluate biomarkers. Analyses were performed separately in CNtoMCI and MCItoAD groups.ResultsFor CNtoMCI (n = 189), there was strong evidence that higher WMH volume (individual model: HR 1.79,p= 0.002; fully adjusted model: HR 1.98,p= 0.003) and lower hippocampal volume (individual: HR 0.54,p= 0.001; fully adjusted: HR 0.40,p< 0.001) were associated with conversion to MCI individually and independently. For MCItoAD (n = 345), lower hippocampal (individual model: HR 0.45,p< 0.001; fully adjusted model: HR 0.55,p< 0.001) and whole-brain volume (individual: HR 0.31,p< 0.001; fully adjusted: HR 0.48,p= 0.02), increased CSF ptau (individual: HR 1.88,p< 0.001; fully adjusted: HR 1.61,p< 0.001), and lower CSF amyloid (individual: HR 0.37,p< 0.001; fully adjusted: HR 0.62,p= 0.008) were most strongly associated with conversion to AD individually and independently.DiscussionLower hippocampal volume was a consistent predictor of clinical conversion to MCI and AD. CSF and brain volume biomarkers were predictive of conversion to AD from MCI, whereas WMH were predictive of conversion to MCI from cognitively normal. The predictive ability of WMH in the CNtoMCI group may be interpreted as some being on a different pathologic pathway, such as vascular cognitive impairment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3